150557-09-8

Basic information

• Product Name: 1-[2-(BENZHYDRYLOXY)ETHYL]-1,4-DIAZEPANE
• Synonyms: BUTTPARK 147\16-70;1-[2-(BENZHYDRYLOXY)ETHYL]-1,4-DIAZEPANE;1-[2-(BENZHYDRYLOXY)ETHYL]HOMOPIPERAZINE;1-[2-(Benzhydryloxy)ethyl]homopiperazine, 1,1'-{[2-(1,4-Diazepan-1-yl)ethoxy]methanediyl}dibenzene;1-[2-(Diphenylmethoxy)ethyl]-1,4-diazepane;1-[2-(Diphenylmethoxy)ethyl]homopiperazine
• CAS NO: 150557-09-8
• Molecular Formula: C₂₀H₂₆N₂O
• Molecular Weight: 310.43
• Product Categories: Ring Systems
• Mol File: 150557-09-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 183/0.5mm
• Appearance: /
• CAS DataBase Reference: 1-[2-(BENZHYDRYLOXY)ETHYL]-1,4-DIAZEPANE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[2-(BENZHYDRYLOXY)ETHYL]-1,4-DIAZEPANE(150557-09-8)
• EPA Substance Registry System: 1-[2-(BENZHYDRYLOXY)ETHYL]-1,4-DIAZEPANE(150557-09-8)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 150557-09-8(Hazardous Substances Data)

Usage

Family

Diazepane

Type

Organic compound

Usage

Pharmaceutical intermediate

Structure

Six-membered diazepane ring with a benzhydryloxyethyl group attached

Derivatives

Benzhydryl alcohol and 1,4-diazepane

Applications

Synthesis of biologically active compounds, antipsychotic and anxiolytic drugs

Potential

Medicinal chemistry and drug discovery

Upstream product

• 505-66-8 1,4-Diazacycloheptane 
• 32669-06-0 1,1'-[(2-chloroethoxy)methylene]bis-benzene 
• 91-01-0 1,1-Diphenylmethanol 

Downstream Products

• 150151-14-7 LR 1111 
• 1028302-99-9 1-[4-(2-Benzhydryloxy-ethyl)-[1,4]diazepan-1-yl]-3-phenyl-propan-1-one 
• 1026363-15-4 (E)-1-[4-(2-Benzhydryloxy-ethyl)-[1,4]diazepan-1-yl]-3-phenyl-propenone 

Relevant articles and documents

Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)

The design, synthesis, and biological evaluation of compounds related to the dopamine (DA) uptake inhibitors: 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (1) and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (2) (GBR

Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses

New pyridylthiazolinecarboxylic acid amide compounds have been found to have a valuable combination of antiallergic and antiasthmatic activities with an antagonist activity against Platelet Activating Factor.